The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Camrelizumab in combination with doxorubicin, cisplatin, ifosfamide, and methotrexate as neoadjuvant therapy for osteosarcoma: A single-arm, exploratory phase II trial.
 
Qinglian Tang
No Relationships to Disclose
 
Xiaojun Zhu
No Relationships to Disclose
 
Guohui Song
No Relationships to Disclose
 
Jinchang Lu
No Relationships to Disclose
 
Hao Wu
No Relationships to Disclose
 
Huaiyuan Xu
No Relationships to Disclose
 
Xin-ke Zhang
No Relationships to Disclose
 
Fei Ai
No Relationships to Disclose
 
Yingchun Zhang
No Relationships to Disclose
 
Jin Wang
No Relationships to Disclose